COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

2020179 citationsJournal Articlehybrid Open Access

Authors

on behalf of the LEOSS Study Group · Jena University Hospital

Maria Madeleine Rüthrich · Jena University Hospital

Clemens Gießen-Jung · Klinikum Ingolstadt

Stefan Borgmann · University of Cologne

Annika Y. Claßen · University of Cologne

Sebastian Dolff · University Hospital Ulm

Beate Grüner ·

Abstract

Comparing cancer and non-cancer patients, outcome of COVID-19 was comparable after adjusting for age, sex, and comorbidity. However, our results emphasize that cancer patients as a group are at higher risk due to advanced age and pre-existing conditions.

Topics & Keywords

COVID-19 and healthcare impacts Healthcare cost, quality, practices COVID-19 Clinical Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Hematology

Volume 100, Issue 2, pp. 383-393

DOI: 10.1007/s00277-020-04328-4

Field-Weighted Citation Impact: 11.48